Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants must be adult and of greater than or equal to (\>=) 18 years of age or older at the time of consent
Participants must be immunocompromised (IC) population eligible to receive sotrovimab
A positive polymerase chain reaction (PCR) or antigen test for SARS-CoV-2 through clinical testing or routine screening undertaken as part of clinical management
Prescribed treatment with sotrovimab as standard of clinical care
Able to provide informed consent and willing to adhere to study-related procedures
You may not be if
Participants who require hospitalization (related or not to COVID-19) at baseline
Participants who initiated sotrovimab therapy in inpatient settings
Participants unable to perform nasal/oropharyngeal sample collection
Blinded participants from other COVID-19 related trials
Clareo Health | Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19
